Anhui Huaheng Biotechnology Co.Ltd(688639) (688639) released the performance express for 2021 on February 22. During the reporting period, the company’s total operating revenue was 954.2833 million yuan, a year-on-year increase of 95.85%; The net profit attributable to the owner of the parent company after deducting non recurring profits and losses was 150.2327 million yuan, a year-on-year increase of 55.28%. By the end of the reporting period, the total assets of the company were 1.536 billion yuan, a year-on-year increase of 106.71%; The owner’s equity attributable to the parent company was 1.195 billion yuan, a year-on-year increase of 143.89%.
Anhui Huaheng Biotechnology Co.Ltd(688639) said that during the reporting period, the company’s product categories were further enriched, the sales scale continued to grow, resulting in a significant increase in the total operating revenue, and the net profit attributable to the owners of the parent company also increased significantly compared with the previous year. Meanwhile, in 2021, the company’s total operating revenue, operating profit, total profit, net profit attributable to the owner of the parent company and net profit attributable to the owner of the parent company after deducting non recurring profits and losses increased significantly, mainly due to the continuous growth of sales scale. At the end of the reporting period, the total assets, owner’s equity attributable to the parent company, share capital and net assets per share attributable to the owner of the parent company increased significantly, mainly due to the availability of funds raised by the company on the science and innovation board during the reporting period and the increase of net profit during the reporting period.
